2021 Speakers

 

Carlos Aceves-González, Associate Professor, Universidad de Guadalajara

Carlos Aceves-González | Associate Professor | Universidad de Guadalajara » speaking at Drug Safety USA

Toyin Adewole, Associate Director, Supernus Pharmaceuticals, Inc.

Toyin Adewole | Associate Director | Supernus Pharmaceuticals, Inc. » speaking at Drug Safety USA

Anupam Agarwal, Vice President Global Head Of Drug Safety And Pv, Zogenix

Omar Aimer, Pharmacovigilance Specialist, Brunel Canada

Omar Aimer | Pharmacovigilance Specialist | Brunel Canada » speaking at Drug Safety USA

Wassim Aldairy, Head Of Pharmacovigilance, Cerevel Therapeutics

Wassim Aldairy | Head Of Pharmacovigilance | Cerevel Therapeutics » speaking at Drug Safety USA

Jason Ancell, Associate Director, Global Risk Management, Bristol Myers Squibb

Jason Ancell | Associate Director, Global Risk Management | Bristol Myers Squibb » speaking at Drug Safety USA

Nicole Baker, Managing Director And Consultant, QPPV

Mr Greg Ball, Senior Principal Statistician, Merck

Khaudeja Bano, Head Of Medical Affairs, Abbott

Khaudeja Bano | Head Of Medical Affairs | Abbott » speaking at Drug Safety USA

Victoria Bartasek, Senior Associate Director, Global Pharmacovigilance, Boehringer Ingelheim Pharma GmbH & Co. KG

Victoria Bartasek | Senior Associate Director, Global Pharmacovigilance | Boehringer Ingelheim Pharma GmbH & Co. KG » speaking at Drug Safety USA

Jim Buchanan, Clinician, Covilance

Jim Buchanan | Clinician | Covilance » speaking at Drug Safety USA

Siva Kumar Buddha, Global Safety Physician Manager Product Safety and Risk Management, Viatris- Mylan

Edward Chow, Executive Director, Toxicology, AbbVie

Edward Chow | Executive Director, Toxicology | AbbVie » speaking at Drug Safety USA

Mircea Ciuca, Therapeutic Area Head Global Clinical Drug Safety, CSL Behring

Shaun Comfort, Principal Science Enablement Director, Genentech

Shaun Comfort | Principal Science Enablement Director | Genentech » speaking at Drug Safety USA

Ms Jacqueline Corrigan-Curay, Director, Office of Medical Policy, Center for Drug Evaluation and Research, FDA

Cristina Damatarca, President and Founder, SafePharm LLC

Kal Elhoregy, Director, Risk Evaluation and Mitigation Strategy (REMS), Amneal Pharmaceuticals

Maritess Esguerra, Senior PV Process Director, Genentech

Maritess Esguerra | Senior PV Process Director | Genentech » speaking at Drug Safety USA

E. Stewart Geary, Global Safety Officer and Senior Vice President, Eisai

Jacqueline Gerena, Director, Program Management (REMS Program), Aimmune Therapeutics

Jacqueline Gerena | Director, Program Management (REMS Program) | Aimmune Therapeutics » speaking at Drug Safety USA

Coryandar Gilvary, Chief Data Scientisit, OneThree Biotech

Coryandar Gilvary | Chief Data Scientisit | OneThree Biotech » speaking at Drug Safety USA

Michael Glaser, Innovation Technology Director, GSK

Lana Gloukhova, Head Of Regions, CSL Behring

Lana Gloukhova | Head Of Regions | CSL Behring » speaking at Drug Safety USA

Aaron Goodstein, Director, Quality Systems, Compliance, Medical Safety And Medicine Doctor, Johnson & Johnson

Aaron Goodstein | Director, Quality Systems, Compliance, Medical Safety And Medicine Doctor | Johnson & Johnson » speaking at Drug Safety USA

Kishore Gopu, Associate Director REMS Programs, Teva Pharmaceuticals

Kishore Gopu | Associate Director REMS Programs | Teva Pharmaceuticals » speaking at Drug Safety USA

Ilona Grosse-Michaelis, Medical Dictionary Expert, Bayer AG

Ilona Grosse-Michaelis | Medical Dictionary Expert | Bayer AG » speaking at Drug Safety USA

Bill Haddock, Head Of Safety, Ovid Therapeutics

Bill Haddock | Head Of Safety | Ovid Therapeutics » speaking at Drug Safety USA

Peter Hawkins, Senior Director, Head Of Rare Genetic Disease Risk Management, Agios Pharmaceuticals

Raúl J. Andrade, Professor of Medicine and Director, Department of Medicine, University of Malaga

Mr Rahul Khajuria, Senior Director, Global Head Of Drug Safety Systems And Analytics, United Therapeutics

Claudia Lehmann, Head Of Global Pharmacovigilance Operations, Boehringer Ingelheim Pharma GmbH & Co. KG

Claudia Lehmann | Head Of Global Pharmacovigilance Operations | Boehringer Ingelheim Pharma GmbH & Co. KG » speaking at Drug Safety USA

Jie Li, Head Of Pharmacovigilance, Greenwich Biosciences

Jie Li | Head Of Pharmacovigilance | Greenwich Biosciences » speaking at Drug Safety USA

Bruno Mendez, VP, Global quality PV, Sanofi Pasteur

Ellen (Lena) Mishalov, Director, Pv Technological Innovations, Astellas Pharma

Ellen (Lena) Mishalov | Director, Pv Technological Innovations | Astellas Pharma » speaking at Drug Safety USA

Madhu Mondal, Director, Toxicology And Safety Pharmacology, Cerevel Therapeutics

Deanna Montes De Oca, Global Head of Case Processing, Director PV Operations, Otsuka

Deanna Montes De Oca | Global Head of Case Processing, Director PV Operations | Otsuka » speaking at Drug Safety USA

Mr Muhammad Ashar Naeem, Global Director Pharmacovigilance And Medical Affair, JAMJOOM PHARMA

Jaylaxmi Nalawade, Associate Director, LUPIN LTD

Jaylaxmi Nalawade | Associate Director | LUPIN LTD » speaking at Drug Safety USA

Kishan Nandha, Manager, Pharmacovigilance Quality Assurance, Astellas Pharma

Kishan Nandha | Manager, Pharmacovigilance Quality Assurance | Astellas Pharma » speaking at Drug Safety USA

Oyinkansola Odebo, Assistant Director Drug Safety, Supernus Pharmaceutical

Oyinkansola Odebo | Assistant Director Drug Safety | Supernus Pharmaceutical » speaking at Drug Safety USA

Meenal Patwardhan, Therapeutic Area Head, Infectious Diseases, Neurosciences, Men and Women's Health, General Medicine, AbbVie

Meenal Patwardhan | Therapeutic Area Head, Infectious Diseases, Neurosciences, Men and Women's Health, General Medicine | AbbVie » speaking at Drug Safety USA

Amanda Paulson, Data Science Fellow, ATOM Accelerating Therapeutics for Opportunities i

Amanda Paulson | Data Science Fellow | ATOM Accelerating Therapeutics for Opportunities i » speaking at Drug Safety USA

Jackie Roberts, Associate Vice President, Scientific Affairs, Governance, Accord Healthcare

Angela Caro Rojas, President, Colombian Pharmacovigilance Association

Angela Caro Rojas | President | Colombian Pharmacovigilance Association » speaking at Drug Safety USA

Maha Saad, Americas Pharmacovigilance Head, Bioresearch Quality And Compliance, Quality Assurance, Johnson & Johnson

Rudi Scheerlinck, Pharmacovigilance Risk Management Clinical Studies, Galderma

Rudi Scheerlinck | Pharmacovigilance Risk Management Clinical Studies | Galderma » speaking at Drug Safety USA

Philip Schneider, Advisory Board Chair, Alliance for Safe Biologic Medicines

Philip Schneider | Advisory Board Chair | Alliance for Safe Biologic Medicines » speaking at Drug Safety USA

Vipin Sethi, Head Of Global Pharmacovigilance And Medical Affairs, Cadila Pharmaceuticals

Kan Shao, Associate Professor Of Environmental And Occupational Health, Indiana University

Kan Shao | Associate Professor Of Environmental And Occupational Health | Indiana University » speaking at Drug Safety USA

Amgad Shebl, Director, Global Clinical Safety And Pharmacovigilance, CSL Behring

Amgad Shebl | Director, Global Clinical Safety And Pharmacovigilance | CSL Behring » speaking at Drug Safety USA

Marina Suvakov, Director, Compliance And Business Management, Otsuka Europe Development and Commercialisation Ltd

Marina Suvakov | Director, Compliance And Business Management | Otsuka Europe Development and Commercialisation Ltd » speaking at Drug Safety USA

Ale Vazquez-Gragg, Global Head of Pharmacovigilance, Orchard Therapeutics

Deepa Venkataraman, Senior Director, Head of Global Case Management and Medical Safety Operations, AbbVie

Deepa Venkataraman | Senior Director, Head of Global Case Management and Medical Safety Operations | AbbVie » speaking at Drug Safety USA

William Wang, Executive Director, Clinical Safety Statistics, Merck

William Wang | Executive Director, Clinical Safety Statistics | Merck » speaking at Drug Safety USA

Syed Zaferuddin, Global Pharmacovigilance Manager and QPPV, Julphar

Syed Zaferuddin | Global Pharmacovigilance Manager and QPPV | Julphar » speaking at Drug Safety USA

Richard C. Zink, Adjunct Professor of Biostatistics, The University of North Carolina at Chapel Hill

Patricia Zuluaga Arias, Vice President, Coordinator of Academic Committee, Colombian Pharmacovigilance Association

Patricia Zuluaga Arias | Vice President, Coordinator of Academic Committee | Colombian Pharmacovigilance Association » speaking at Drug Safety USA

Get Involved At Drug Safety Congress Americas

 

To Sponsor Or Exhibit


Semen Sen
Semen.sen@terrapinn.com
t/ +1 646 619 1793

 

 

To Speak


Joan Shutt
joan.shutt@terrapinn.com
t/ +1 646 619 1775

 

 

Marketing & Press Opportunities


Taylor Post
taylor.post@terrapinn.com
t/ +1 646 619 1785